Drug Safety

, Volume 36, Issue 7, pp 505–513 | Cite as

Probabilistic Record Linkage for Monitoring the Safety of Artemisinin-Based Combination Therapy in the First Trimester of Pregnancy in Senegal

  • Stephanie Dellicour
  • Philippe Brasseur
  • Per Thorn
  • Oumar Gaye
  • Piero Olliaro
  • Malik Badiane
  • Andy Stergachis
  • Feiko O. ter Kuile
Short Communication

Abstract

Background

There are insufficient data on the safety in early pregnancy of the artemisinins, a new class of antimalarials. Assessment of drug teratogenicity requires large sample sizes for an adequate risk-benefit assessment. There is currently limited pharmacovigilance infrastructure in malaria-endemic countries. Monitoring drug safety in early pregnancy is especially challenging, as it requires early pregnancy detection to assess any potential increased risk of miscarriage, prospective follow-up to reduce recall and survival biases, and accurate data on gestational age assessment. Record linkage approaches for pregnancy pharmacovigilance using routinely generated health records could be a pragmatic and cost-effective approach for pharmacovigilance in early pregnancy, but has not been evaluated in resource-poor settings.

Objective

Our objective was to assess the feasibility of record linkage using routinely collected healthcare data as a pragmatic means of monitoring the safety in early pregnancy of artemisinin-based combination therapies (ACTs) in Senegal.

Methods

Data (2004–2008) from paper-based registers from outpatient clinics, antenatal care services (ANC) and the delivery unit from the St Joseph dispensary in Mlomp, south-western Senegal, were entered into databases. Record linkage based on a probabilistic matching approach was used to identify pregnancies exposed to ACTs in the first trimester of pregnancy. Two record linkage software packages (Link-Plus and FRIL) were compared and output data were reviewed independently by two investigators.

Results

Information on 685 pregnancies was extracted, 536 of which were from the geographic catchment area and eligible for record linkage; 94.6 % of them resulted in live births, 2.6 % in stillbirths and 2.8 % in miscarriages. Major congenital malformations were identified in 1.6 % of births. Seventy-three and 75 true matches between pregnancy outcome and the outpatient treatment registers were identified by two different record linkage software packages, respectively. Record linkage identified seven exposures to ACTs in the first trimester, all of which resulted in normal live-births.

Conclusion

Probabilistic record linkage is a potentially cost-effective method to assess the safety of antimalarials in early pregnancy in resource-constrained settings to assess increased risk of overall birth defects, and stillbirths in settings with good existing health records and well defined target populations.

Keywords

Artemisinin Record Linkage True Match Last Menstrual Period Health Facility Delivery 

Notes

Acknowledgments

This work was made possible by the dedication of the healthcare personnel of St Joseph Dispensary in Mlomp and the help of Sister Marie Joelle.

Funding

SD is partly funded by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. SD is also grateful to the US Centers for Disease Control and Prevention for salary support through a cooperative agreement between the Division of Parasitic Diseases and Malaria (Centers for Disease Control and Prevention, USA) and the Malaria Epidemiology Unit of the Child and Reproductive Health group, Liverpool School of Tropical Medicine held by FtK. Travel expenses for SD and PT were covered by a pharmacovigilance planning grant from the Bill & Melinda Gates Foundation to the University of Washington held by AS.

Conflict of interest

The authors declare no conflict of interest. PO is a staff member of the WHO; the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy or views of the WHO.

Author’s contributions SD, FtK, OG and PO contributed to the concept of the project. SD and FtK developed the protocol with contributions from PO, PB and AS. SD and PT conducted the data collection and record linkage analyses. PB supervised the data collection. SD and FtK wrote the first draft of the manuscript; all authors reviewed and revised the final version.

Supplementary material

40264_2013_59_MOESM1_ESM.pdf (227 kb)
Supplementary material 1 (PDF 226 kb)

References

  1. 1.
    WHO. Assessment of the safety of artemisinin compounds in pregnancy. Report of two informal consultations convened by WHO in 2002. Geneva: WHO; 2003.Google Scholar
  2. 2.
    WHO, TDR. Assessment of the safety of artemisinin compounds in pregnancy: report of two joint informal consultations convened in 2006 by The Special Programme for Research and Training in Tropical Diseases (TDR) sponsored by UNICEF/UNDP/World Bank/WHO. Geneva: WHO; 2006.Google Scholar
  3. 3.
    Kennedy DL, Uhl K, Kweder SL. Pregnancy exposure registries. Drug Saf. 2004;27(4):215–28.PubMedCrossRefGoogle Scholar
  4. 4.
    Källén BA. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom (Kyoto). 2005;45(2):44–51.CrossRefGoogle Scholar
  5. 5.
    Hernandez-Diaz S, Hernan MA, Meyer K, Werler MM, Mitchell AA. Case-crossover and case-time-control designs in birth defects epidemiology. Am J Epidemiol. 2003;158(4):385–91.PubMedCrossRefGoogle Scholar
  6. 6.
    Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157(3):175–82.PubMedCrossRefGoogle Scholar
  7. 7.
    Andrews EB, Tennis P. Promise and pitfalls of administrative data in evaluating pregnancy outcomes. Pharmacoepidemiol Drug Saf. 2007;16(11):1181–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Charlton RA, Weil JG, Cunnington MC, Ray S, de Vries CS. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations. Drug Saf. 2011;34(2):157–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Colvin L, Slack-Smith L, Stanley FJ, Bower C. Pharmacovigilance in pregnancy using population-based linked datasets. Pharmacoepidemiol Drug Saf. 2009;18(3):211–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM. Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland. Drug Saf. 2010;33(7):593–604.PubMedCrossRefGoogle Scholar
  11. 11.
    Dellicour S, Ter Kuile FO, Stergachis A. Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. PLoS Med. 2008;5(9):e187.PubMedCrossRefGoogle Scholar
  12. 12.
    Corbell C, Katjitae I, Mengistu A, Kalemeera F, Sagwa E, Mabirizi D, et al. Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa. Pharmacoepidemiol Drug Saf. 2012;21(4):407–14.Google Scholar
  13. 13.
    Fellegi IP, Sunter AB. A theory for record linkage. J Am Stat Assoc. 1969;64(328):1183–210.CrossRefGoogle Scholar
  14. 14.
    Jaro MA. Probabilistic linkage of large public health data files. Stat Med. 1995;14(5–7):491–8.Google Scholar
  15. 15.
    Meray N, Reitsma JB, Ravelli AC, Bonsel GJ. Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number. J Clin Epidemiol. 2007;60(9):883–91.PubMedCrossRefGoogle Scholar
  16. 16.
    Newcombe H, Kennedy J. Record linkage: making maximum use of the discriminating power of identifying information. Commun ACM. 1962;5(11):563–6.CrossRefGoogle Scholar
  17. 17.
    Brasseur P, Badiane M, Cisse M, Agnamey P, Vaillant MT, Olliaro PL. Changing patterns of malaria during 1996–2010 in an area of moderate transmission in southern Senegal. Malar J. 2011;10:203.PubMedCrossRefGoogle Scholar
  18. 18.
    Enel C, Pison G, Lefebvre M. De l’accouchement traditionnel à l’accouchement moderne au Sénégal. Cahiers Santé. 1993;3:441–6.Google Scholar
  19. 19.
    Pison G, Kodio B, Guyavarch E, Etard J-F. La mortalité maternelle en milieu rural au Sénégal. Population. 2000;55(6):1003–18.CrossRefGoogle Scholar
  20. 20.
    Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, et al. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal. Malar J. 2008;7:234.PubMedCrossRefGoogle Scholar
  21. 21.
    US Centers for Disease Control and Prevention. Registry Plus™ Link Plus technical information and installation. Atlanta (GA): CDC; 2006 [online]. http://www.cdc.gov/cancer/npcr/tools/registryplus/lp_tech_info.htm. Accessed 24 Apr 2013.
  22. 22.
    Jurczyk P. Fine-grained record integration and linkage tool. Open source record linkage software. 2.1.4 edn. Atlanta (GA), 2009.Google Scholar
  23. 23.
    Jurczyk P, Lu JJ, Xiong L, Cragan JD, Correa A. Fine-grained record integration and linkage tool. Birth Defects Res A Clin Mol Teratol. 2008;82(11):822–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet. 2006;367(9521):1487–94.PubMedCrossRefGoogle Scholar
  25. 25.
    NPCR. Link Plus Development Priority List (updated January 26, 2011). 2011. http://www.cdc.gov/cancer/npcr/tools/registryplus/lp_features.htm. Accessed 7 Feb 2012.
  26. 26.
    McGready R, Lee SJ, Wiladphaingern J, Ashley EA, Rijken MJ, Boel M, et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population based study. Lancet Infect Dis. 2012;12(5):388–96.PubMedCrossRefGoogle Scholar
  27. 27.
    Desai M, Dellicour S. Effects of malaria and its treatment in early pregnancy. Lancet Infect Dis. 2012;12(5):359–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Gomes M. New global pregnancy register established. 2009 [online]. http://www.who.int/maternal_child_adolescent/news_events/news/2009/pregnancy_register/en/index.html. Accessed 15 May 2012.
  29. 29.
    MiPc. Malaria in Pregnancy Consortium. 2012. http://www.mip-consortium.org/. Accessed 2012.
  30. 30.
    Romitti PA, Watanabe-Galloway S, Budelier WT, Lynch CF, Puzhankara S, Wong-Gibbons D, et al. Identification of Iowa live births in the Agricultural Health Study. Arch Environ Occup Health. 2010;65(3):154–62.Google Scholar
  31. 31.
    Roos LL Jr, Wajda A, Nicol JP. The art and science of record linkage: methods that work with few identifiers. Comput Biol Med. 1986;16(1):45–57.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  • Stephanie Dellicour
    • 1
    • 2
    • 3
  • Philippe Brasseur
    • 4
  • Per Thorn
    • 5
  • Oumar Gaye
    • 6
  • Piero Olliaro
    • 7
    • 8
  • Malik Badiane
    • 9
  • Andy Stergachis
    • 10
  • Feiko O. ter Kuile
    • 1
  1. 1.Child and Reproductive Health GroupLiverpool School of Tropical MedicineLiverpoolUK
  2. 2.Center for Global Health Research (CGHR)Kenya Medical Research Institute (KEMRI)KisumuKenya
  3. 3.Graduate SchoolAcademic Medical CentreAmsterdamThe Netherlands
  4. 4.Institut de Recherche pour le Développement (IRD)DakarSenegal
  5. 5.Thorn IT Services LimitedLondonUK
  6. 6.Faculté de Médecine, Service de ParasitologieUniversité Cheikh Anta DiopDakarSenegal
  7. 7.UNICEF/UNDP/WB/WHO Special Programme for Research and Training in Tropical Diseases (TDR)GenevaSwitzerland
  8. 8.Nuffield Department of Medicine, Centre for Tropical Medicine and Vaccinology, Churchill HospitalUniversity of OxfordOxfordUK
  9. 9.District Médical d’OussouyeOussouyeSenegal
  10. 10.Departments of Epidemiology and Global Health, Global Medicines Program, School of Public HealthUniversity of WashingtonSeattleUSA

Personalised recommendations